The early time course after acute stroke of cerebral JV-acetylaspartate, creatine and phosphocreatine, and compounds containing choline was studied in vivo by means of localized water-suppressed proton magnetic resonance spectroscopy.
B
y means of proton magnetic resonance spectroscopy ('H-MRS), it has become possible to detect a number of metabolites in the brain, including JV-acetylaspartate (NAA), creatine and phosphocreatine (Cr+PCr), and compounds containing choline (Cho). Using the unsaturated water signal as the internal standard, average concentrations of these metabolites in a volume of interest (VOI) can be approximated by assuming an average fractional water concentration in brain tissue.
1 -2 These studies suggest concentrations in normal 1 . 2 The role of NAA in the brain is largely unknown. Koller et al 3 showed that NAA existed in higher concentrations in gray matter than in white matter and disappeared after injection of the neurotoxin kainic acid into the neurons. A number of studies indicate that NAA is largely present within neurons. 4 Thus, NAA may be used as a neuronal marker to study the number of viable neurons in the brain tissue.
s Phosphocreatine serves as a reserve for high-energy phosphates most prominently in neurons and muscle cells 6 and buffers cellular ATP reservoirs. The proton resonance peak in vivo represents the composite signal of Cr+PCr. 67 The Cho peak observed probably represents the major water-soluble Cho-containing compounds in the brain, including choline, glycerophosphocholine, and phosphocholine. 6 -(Pi) ratio and acidic pH after the onset of ischemia, after which 31 P-MRS spectra quickly returned to normal. 8 - 9 Proton spectroscopy has demonstrated rapid formation of lactate during ischemia after clipping of the carotid artery, and a gradual reduction of lactate content to normal values after restoration of blood supply. 9 Studies of rat brain indicate that NAA, Cr+PCr, and Cho levels are markedly decreased after the induction of ischemia. 10 It should be emphasized, however, that such animal models may not be directly comparable to human pathology; differences in collateral perfusion may constitute a major problem.
Studies of brain infarction in humans using 31 P-MRS have shown reduction in the PCr/Pi ratio only within the first week and acidic pH only within the first 32 hours after stroke, after which pH became alkalotic in the subacute phase and subsequently returned to normal.
11
-12 This is in agreement with earlier positron emission tomographic studies. 13 No changes in metabolic ratios or pH were found in human chronic infarction 14 ; however, a decrease of up to 40% of the total phosphorous signal of infarcted tissue was observed.
Preliminary studies using 'H-MRS in humans indicate that acute stroke is followed by loss of NAA in the infarcted brain tissue. 15 -17 Recent studies indicate a decrease of NAA, Cr+PCr, and Cho after acute stroke.
18
- 19 These studies, however, do not permit quantification because the Tl and T2 relaxation rates of the metabolites in question were not taken into account.
Therapeutic approaches aimed at reducing the neurological deficits after acute stroke depend on a better understanding of the pathophysiological mechanisms operating during severe cerebral ischemia. Thus, estimation of the early time course of neuronal death or survival after acute stroke in humans, as suggested by changes in the NAA content, may be of particular clinical importance.
To our knowledge, no studies have been reported describing serial measurements of early changes of NAA, Cr+PCr, and Cho in infarcted brain tissue, including measurement of regional cerebral blood flow (rCBF) after acute stroke in humans. This study therefore focuses on the following issues: early changes in NAA, PCr+Cr, and Cho contents after acute stroke; the regional variation of metabolite contents within the infarcted area; and the time course of relative rCBF in the infarcted area.
Subjects and Methods
Our study comprises eight patients with acute stroke (age range, 27-80 [mean±SD, 58.4±19.7] years). 'H-MRS and rCBF measurements were carried out between 6 and 52 hours after the onset of symptoms, with the time between the 'H-MRS measurement and the rCBF measurement ranging between 6 and 24 hours. The measurements were repeated 1 week and 2-4 weeks after the stroke incident. For comparison, 10 age-matched (50.1 ±22.9 [range, years) healthy volunteers were examined with 'H-MRS. The study was approved by the local ethics committee, and informed consent was obtained in all cases.
rCBF Measurements
The rCBF was measured in eight slices using a brain-dedicated single-photon emission computed tomography (SPECT) camera (Tomomatic 232), with 500 MBq ""Tc-labeled d,/-hexamethylenepropyleneamine oxime injected intravenously used as a flow tracer. (A detailed discussion of this method was given in a recent review. 20 ) The three-dimensional spatial resolution of SPECT was 12-13 mm full-width at half-maximum. Linearization correction for back diffusion was carried out according to Lassen et al. 21 A contralateral, symmetrically located region was used as reference for the calculation of relative rCBF.
'H-MRS Measurements
The 'H-MRS experiments were carried out on a Siemens Helicon SP 63/84 whole-body magnetic resonance imaging (MRI) scanner operating at 1.5 T using a circularly polarized headcoil.
Water-suppressed 'H-MRS was obtained using a stimulated echo sequence as described by Frahm et al. 22 The region of infarction was visualized using a multislice, double-spin echo sequence in the transverse plane with a repetition time (TR) of 2.2 seconds and echo times (TE) of 15 and 90 msec. A VOI was placed within the pathological region, with care taken to avoid inclusion of cerebrospinal fluid. The magnetic field was shimmed globally and locally within the selected VOI to a spectral width at half-maximum of the water signal of 3-6 Hz in both regions. At the examinations 1 week and 2-4 weeks after stroke, great care was taken to place the VOI in the same location as before, guided by anatomic landmarks in the images ( Figures 1A and 2A) . The VOI ranged between 18 ml (3x3x2 cm 3 ) and 27 ml (3x3x3 cm 3 ). To evaluate possible regional variations, additional measurements in a smaller VOI were carried out, with a volume of 8 ml (2x2x2 cm 3 ) placed at the center of the first VOI.
The proton spectra from the VOI and the smaller central VOI were measured with TE=46, 135, and 270 msec, and TR=1.5 seconds. The middle interval (TM) was 30 msec. The number of acquisitions ranged between 128 and 512. To estimate Tl saturation, supplementary measurements were carried out in all patients with TE=46 msec and TR=6.0 seconds. For each echo time, the unsaturated water signal in the VOI was obtained in one acquisition by setting the amplitude of the Gaussian water suppression radio frequency pulses to zero.
Calculations and Statistics
The signals in the time domain were multiplied by a half Gaussian function with a half-width of 256 msec. After Fourier transformation and zero-order phase correction, the spectra were baseline corrected using a second-order spline function. The areas under the peaks were obtained manually using the software of the manufacturer (numerical integration). To minimize interindividual as well as intraindividual variations in measurement sensitivity, the calculated metabolite signals were scaled with the unsaturated water signal (internal standard). 2 ' 23 Correction for the T2 decay was done by extrapolation of the signal versus echo time to time zero using a single exponential function.
The signals arising from the "peripheral volume" were calculated by subtracting the signals of the central cube from those obtained in the total volume. The Friedmann two-way analysis of variance by ranks was used for test of significance of the relative metabolite signals with time within the patient group. The Mann-Whitney rank sum test for unpaired samples was used for test of significance between the metabolite signals from the patient group in the acute phase and the control group. The level of significance was set at /?<0.05. 
Results

Examples
rCBF
The mean relative rCBF was reduced to about 51% (range, 28-73%) at the center of the infarcted areas at the time of the first examination. All but one patient developed reperfusion hyperemia during the following 2-4 weeks. The average values are summarized in Table 1 .
'H-MRS
Examples of 'H-MRS spectra obtained at day 1 and after 1 week are shown in Figure 3 . Resonances were assigned, according to Michaelis et al, 7 as follows: 1) Cr+PCr-methylene singlet at 3.94 ppm; 2) inositols at 3.56 ppm; 3) Cho at 3.22 ppm; 4) Cr+PCr-methyl singlet at 3.03 ppm; 5) NAA-aspartyl group at 2.48, 2.60, and 2.66 ppm; 6) NAA-methyl singlet at 2.01 ppm; and 7) lactate at 1.33 ppm. Peak 7 is known to be lactate; spectra were also obtained at TE=135 msec and 270 msec, and the peak exhibited the phase changes characteristic for lactate.
Acute Phase
In the acute phase, the NAA signal relative to water of 1.8X10" 4 (range, 0.0-4.1) was lower than that of 4.0X10" 4 (range, 3.1-4.9) observed in the control group (p<0.01; Figure 4 ). The measured NAA content versus time in the acute phase is shown in Figure 5 . It is seen that the NAA content decreased from the normal range to very low levels between 6 and 52 hours after the onset of symptoms. In Figure 5 , the estimated NAA concentrations are shown, assuming a fractional water content of 0.75. 24 Using this assumption, the mean NAA concentration was 11.1 (range, 8.6-13.6) mM in the control group and 5.0 (range, 0.0-11.4) mM in the patient group.
The Cr+PCr concentrations in the patient group in the acute phase were significantly lower than those in the control group (/?<0.02), whereas no significant difference in Cho concentrations was seen between the two groups (p>0.1; Figure 4 ). Assuming a fractional water content of 0.75, the mean Cr+PCr concentration was 7.2 (range, 5.8-9.5) mM in the control group and 5.6 (range, 2.8-7.8) mM in the patient group in the acute phase. For Cho, the mean concentration was 1.8 (range, 1.1-2.4) mM in the control group and 1.3 (range, 0.7-1.9) mM in the patient group.
Lactate content was found in all patients in the acute phase.
Time Course
No significant change in the NAA content was observed 1 week or 2-4 weeks after acute stroke, and no significant changes in relative signals with time were seen for Cho or Cr+PCr. The lactate content decreased to undetectable levels 2-4 weeks after stroke in all patients. 
.
1 . 
FIGURE 4. Metabolite signals relative to unsaturated water signal in patients (P) obtained at examination in acute phase compared with control subjects (C). Horizontal bars represent mean values. N-Acetylaspartate (NAA) content is considerably reduced within the infarcted area. Cr+PCr, creatine and phosphocreatine; CHO, choline.
Regional Variation
In six patients, regional variation of the NAA content was estimated during the acute phase and 2-4 weeks after. As shown in Figure 6 , the NAA signal was lower in the central part than in the outer part of the affected area during the acute phase in five of the six patients studied (p<0.05). In the sixth patient, no NAA signal was seen in the total volume measured. The same trend was seen at 2-4 weeks after the clinical incident.
Discussion
The main results of the present study are that the NAA content in infarcted brain tissue is considerably reduced compared with normal brain tissue; this is in agreement with earlier reports. 15 - 19 The decrease appears to occur mainly between 6 (in one patient) and 24 hours after the clinical incident. The loss of NAA seems to be greater in the central than in the outer part of the VOI, suggesting a heterogeneous distribution of NAA within the infarcted area as visualized by MRI. The Cr+PCr content also appears to be reduced in the infarcted area, whereas no significant changes occurred in the Cho content.
Methodological Considerations
Quantification of the metabolite concentrations in the brain using the unsaturated water signal as the internal standard depends on conditions related to experimental as well as biological factors. 2 The experimental factors include signal linearity, with the amount of metabolites and good volume selection avoiding signals from the brain tissue outside the VOI. Moreover, the spectral resolution must be sufficient to avoid overlapping of peaks in the spectrum.
The biological factors include the water concentration remaining constant during the actual changes in pathophysiological conditions and known for absolute quantification. The metabolites studied should be fully MRS visible, and the Tl and T2 relaxation behavior must be known.
Even with all these conditions fulfilled, it is possible to calculate only the average concentration of the metabolites in the selected VOI.
The instrumental factors have been tested in a series of phantom studies using water solutions of NAA at different concentrations within the biological range. 2 The results show an excellent linearity of the NAA signal with selected volume size as well as with NAA concentration. The absolute error in calculation of NAA concentration was approximately 1 mM. In vitro studies on a two-compartment phantom showed less than 1% contamination by signals from outside the selected volume. 2 The same linearity of metabolite signals versus volume size (8 ml, 15.6 ml, and 27 ml) was found in the occipital lobe in five healthy volunteers. 2 This finding indicates that the fractional water content of brain tissue does not vary significantly under the present measurement conditions.
When using an external standard, 1 variations in signal amplitudes due to Bl field inhomogeneity and static field inhomogeneity may occur. Furthermore, the use of an external standard is dependent on instrumental settings, including receiver gain, coil sensitivity, and radio-frequency inhomogeneity. 12 Concerning the biological factors, the Tl and T2 relaxation behavior was estimated at each investigation. The Tl and T2 relaxation rates of the three metabolites did not differ significantly from those measured in the control group; furthermore, no significant changes were seen during the time course of infarction. 25 The T2 relaxation rate of water in the acute phase was not significantly longer in the patient group compared with the control group; however, at the later examinations the calculated T2 relaxation rates of water were significantly longer in the patient group, indicating edema. The changes in the T2 relaxation rates of water with time in the patient group were not significant. 25 We used the metabolite ratios in the acute phase, in which the T2 of water was not significantly longer, in the comparison with the control group, as the same assumed fractional water content could reasonably be used for the calculation.
It is not known at present whether the metabolites measured in this study are all fully MRS visible. However, the measured NAA concentrations tend to be higher than those measured by direct chemical analysis, 4 which suggests that NAA at least may be fully MRS visible.
With regard to the fractional water concentration, we used a value of 75% (representing a mean value of white matter [71%] and gray matter [81%] 24 ) in the calculation of the absolute concentrations. The water content may increase due to formation of edema during the hyperemic period in the first week after stroke. The maximal error is 33%, if the water concentration is 100%, assuming that all water is MRS visible. The error is probably less than 10% underestimation of the concentrations, as we did not observe any significant change in the T2 relaxation behavior of the water signal with time. 25 Regarding spectral resolution, we cannot exclude that other Af-acetyl moieties may contribute to the resonance peak observed at 2 ppm. Frahm et al 26 have found a resonance peak at 2.045 ppm in a human brain region consisting mainly of white matter and suggest that this accounts for up to 20% of the peak area assigned to NAA. They tentatively assigned this peak to Af-acetylneuraminic acid. Thus, the concentration of NAA may be overestimated by 20% in normal white matter corresponding to about 2 mM.
Based on these considerations, we suggest that even though the absolute concentration values can be regarded only as first-order approximations with an uncertainty of approximately 20%, methodological errors do not hamper the main conclusions indicated above.
The calculated metabolite concentrations in the agematched control group in this study are in agreement with the values reported earlier. With regard to the rCBF measurements, we calculated the relative perfusion as the ratio of the count rate in the infarcted and symmetrically located nonaffected area, corrected for early washout of the tracer according to Lassen et al. 21 However, our results may be influenced by scatter of radiation, yielding an overestimation of the amount of tracer in the infarcted area in the acute hypoperfusion phase. 20 On the other hand, in the later phase the hyperemic perfusion may be underestimated due to initial washout of the tracer. Thus, the calculated relative rCBF in the acute phase reflects maximum values, and those obtained in the hyperemic phase represent minimum values. All in all, this indicates that the observed increase in relative perfusion with time represents a minimum value.
Pathophysiological Implications
Heterogeneous distribution of NAA within the infarcted area. Our results indicate a heterogeneous distribution of NAA within the affected volume shown by MRI. Partial volume effects are probably of minor importance because we found a clearly reduced NAA content in the outer volume as well as in the inner volume. The tendency toward a greater loss of NAA in the central part of the lesion is compatible with the finding that the reduction in blood flow is greater in the central part as well (Table 1) . Thus, these findings support the concept of a "penumbra zone" with viable neurons in the ischemic periphery of the lesion. 27 Time course of NAA content. Our results may suggest that the loss of NAA occurs between 6 and 24 hours after the onset of clinical symptoms. Ideally, repetitive studies on the same patients during the acute phase within 24 hours should be carried out. This, however, is almost impossible to accomplish in practice. Because there is evidence suggesting that NAA for all purposes is located exclusively within neurons, 3 ' 4 the observed decrease in NAA concentration indicates neuronal loss. Assuming that the NAA concentration correlates with the number of surviving neurons, 3 our results suggest that neuronal damage or loss occurs after 6 hours of severe ischemia. This is in agreement with experimental findings in animals. 828 The question now is whether the neuronal damage is reversible when the blood flow is reestablished during the reperfusion hyperemia. It must be emphasized that we did not observe any increase of the NAA content during hyperemia in the patients who showed no NAA content during the ischemic phase. We therefore believe that the loss of NAA is mostly irreversible.
Creatine+phosphocreatine and choline. We observed a significant decrease in the Cr+PCr content at the first examination. One important methodological implication is that this peak does not remain stable and is therefore unsuitable as an internal standard for in vivo quantification of metabolite concentrations in the brain by MRS. 29 In the acute phase, the decrease in Cr+PCr may reflect changes in energy metabolism with reduced uptake or increased loss of Cr. However, in the later phase, during hyperemia the persistent reduction in the Cr+PCr content supports earlier findings that gliotic tissue contains less Cr+PCr than does neuronal tissue. 6 The Cho content was within the normal range, and we did not observe significant changes with time. Duijn et al, 19 in a recent study, found that Cho was reduced approximately 54% compared to the contralateral hemisphere.
